EUVIMEDEUVIMED entdecken
Crossref

Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer

Matteo Lambertini, Marcello Ceppi, Richard A Anderson, David A Cameron, Marco Bruzzone, Maria Alice Franzoi, Claudia Massarotti, Sarra El-Abed, Yingbo Wang, Christophe Lecocq, Paolo Nuciforo, Rebecca Rolyance und 16 weitere

Journal of the National Comprehensive Cancer Network · 2023-01 · 21 (1) · 33-41.e16

DOI: 10.6004/jnccn.2022.7065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-01. Verfasst von Matteo Lambertini und 27 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Genova, Genova, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Ovarian Reserve. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The potential gonadotoxicity of anti-HER2 agents remains largely unknown, and limited, conflicting evidence exists for taxanes. Antimüllerian hormone (AMH) is an established biomarker of ovarian reserve that may aid in quantifying anticancer treatment–induced gonadotoxicity. Patients and Methods: The present biomarker analysis of the randomized phase III neoadjuvant NeoALTTO trial included premenopausal women aged ≤45 years at diagnosis of HER2-positive early breast cancer with available frozen serum samples at baseline (ie, before anticancer treatments), at week 2 (ie, the “biological window” of anti-HER2 therapy alone), and/or at the time of surgery (ie, after completing paclitaxel + anti-HER2 therapy, before starting adjuvant chemotherapy).

Results

The present analysis included 130 patients with a median age of 38 years (interquartile ratio [IQR], age 33–42 years). AMH values at the 3 time points differed significantly ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsOvarian ReserveHumansFemaleAdultPaclitaxelLapatinibBiomarkers

Stichwörter der Autor:innen

Anti-Mullerian hormoneanti-HER2 therapybreast cancergonadotoxicitypaclitaxel

Substanzen

PaclitaxelLapatinibBiomarkers

Autor:innen und Institutionen

  • School of Medicine, University of Genova, Genova, Italy.
  • UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom.
  • Institute of Genomics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom.
  • Gustave Roussy, Villjuif, France.

Förderung

  • Medical Research Council

Zitieren

APA

Lambertini, M., Ceppi, M., Anderson, R. A., Cameron, D. A., Bruzzone, M., Franzoi, M. A., Massarotti, C., El-Abed, S., Wang, Y., Lecocq, C., Nuciforo, P., Rolyance, R., Pusztai, L., Sohn, J., Latocca, M. M., Arecco, L., Pistilli, B., Ruddy, K. J., Ballestrero, A., …, & Demeestere, I. (2023). Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. Journal of the National Comprehensive Cancer Network, 21(1), 33-41.e16. https://doi.org/10.6004/jnccn.2022.7065

Vancouver

Lambertini M, Ceppi M, Anderson RA, Cameron DA, Bruzzone M, Franzoi MA, et al. Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. Journal of the National Comprehensive Cancer Network. 2023;21(1):33-41.e16. doi:10.6004/jnccn.2022.7065

BibTeX
@article{Lambertini2023,
  author = {Lambertini, Matteo and Ceppi, Marcello and Anderson, Richard A and Cameron, David A and Bruzzone, Marco and Franzoi, Maria Alice and Massarotti, Claudia and El-Abed, Sarra and Wang, Yingbo and Lecocq, Christophe and Nuciforo, Paolo and Rolyance, Rebecca and Pusztai, Lajos and Sohn, Joohyuk and Latocca, Maria Maddalena and Arecco, Luca and Pistilli, Barbara and Ruddy, Kathryn J and Ballestrero, Alberto and Del Mastro, Lucia and Peccatori, Fedro A and Partridge, Ann H and Saura, Cristina and Untch, Michael and Piccart, Martine and Di Cosimo, Serena and de Azambuja, Evandro and Demeestere, Isabelle},
  title = {Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2023},
  volume = {21},
  number = {1},
  pages = {33--41.e16},
  doi = {10.6004/jnccn.2022.7065}
}
Kostenlos starten →